Sana Biotechnology, Inc. reports

Location
188 East Blaine Street, Suite 400, Seattle, WA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
9/14/2024, 04:05 AM
Form type Sec Links Description Filing date Reporting date
8-K Report | Data 8-K Sep 12, 2024 Sep 6, 2024
10-Q Report | Data 10-Q Aug 8, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 8, 2024 Aug 8, 2024
8-K Report | Data 8-K Jun 7, 2024 Jun 6, 2024
10-Q Report | Data 10-Q May 8, 2024 Mar 31, 2024
8-K Report | Data 8-K May 8, 2024 May 8, 2024
8-K Report | Data 8-K Apr 18, 2024 Apr 18, 2024
SC 13G/A Report Apr 3, 2024
SC 13G/A Report Mar 7, 2024
10-K Report | Data 10-K Feb 29, 2024 Dec 31, 2023
8-K Report | Data 8-K Feb 29, 2024 Feb 29, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#2) Feb 9, 2024
SC 13G/A Report Feb 9, 2024
8-K Report | Data 8-K Feb 8, 2024 Feb 7, 2024
8-K Report | Data 8-K Feb 7, 2024 Feb 7, 2024
SC 13G/A Report Jan 26, 2024
8-K Report | Data 8-K Jan 9, 2024 Jan 9, 2024
8-K Report | Data 8-K Dec 11, 2023 Dec 11, 2023
10-Q Report | Data 10-Q Nov 8, 2023 Sep 30, 2023
8-K Report | Data 8-K Nov 8, 2023 Nov 8, 2023
8-K Report | Data 8-K Oct 10, 2023 Oct 10, 2023
8-K Report | Data 8-K Sep 13, 2023 Sep 12, 2023
8-K Report | Data 8-K Aug 21, 2023 Aug 17, 2023
10-Q Report | Data 10-Q Aug 3, 2023 Jun 30, 2023
8-K Report | Data 8-K Aug 3, 2023 Aug 3, 2023
8-K Report | Data 8-K Jun 9, 2023 Jun 8, 2023
8-K Report | Data 8-K Jun 7, 2023 Jun 7, 2023
10-Q Report | Data 10-Q May 8, 2023 Mar 31, 2023
8-K Report | Data 8-K May 8, 2023 May 8, 2023
8-K Report | Data 8-K - AGARWAL TRANSITION AGREEMENT Apr 28, 2023 Apr 28, 2023
SC 13G Report Apr 26, 2023
8-K Report | Data 8-K - MANAGEMENT CHANGES Apr 10, 2023 Apr 10, 2023
10-K Report | Data 10-K Mar 16, 2023 Dec 31, 2022
8-K Report | Data 8-K Mar 16, 2023 Mar 16, 2023
SC 13G/A Report ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#1) Feb 13, 2023
SC 13G/A Report Feb 9, 2023
8-K Report | Data 8-K- IND Jan 26, 2023 Jan 26, 2023
8-K Report | Data 8-K Jan 26, 2023 Jan 26, 2023
SC 13G/A Report Jan 20, 2023
8-K Report | Data 8-K Jan 10, 2023 Jan 10, 2023
8-K Report | Data 8-K Nov 29, 2022 Nov 29, 2022
10-Q Report | Data 10-Q Nov 2, 2022 Sep 30, 2022
8-K Report | Data 8-K Nov 2, 2022 Nov 2, 2022
8-K Report | Data 8-K - AMENDED CODE OF CONDUCT Nov 1, 2022 Oct 27, 2022
10-Q Report | Data 10-Q Aug 4, 2022 Jun 30, 2022
8-K Report | Data 8-K Aug 4, 2022 Aug 4, 2022
8-K Report | Data 8-K Jun 14, 2022 Jun 14, 2022
8-K Report | Data 8-K Jun 9, 2022 Jun 6, 2022
8-K Report | Data 8-K Jun 1, 2022 Jun 1, 2022
SC 13G Report May 19, 2022
10-Q Report | Data 10-Q May 10, 2022 Mar 31, 2022
8-K Report | Data 8-K May 10, 2022 May 10, 2022
10-K Report | Data 10-K Mar 16, 2022 Dec 31, 2021
8-K Report | Data 8-K Mar 16, 2022 Mar 16, 2022
SC 13G Report SC 13G Feb 14, 2022
SC 13G Report SC 13G Feb 14, 2022
SC 13G Report ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G Feb 10, 2022
SC 13G/A Report Feb 9, 2022
SC 13G Report Jan 26, 2022
8-K Report | Data 8-K - NIH AND JPM Jan 11, 2022 Jan 7, 2022
10-Q Report | Data 10-Q Nov 8, 2021 Sep 30, 2021
8-K Report | Data 8-K Nov 8, 2021 Nov 8, 2021
8-K Report | Data 8-K Oct 19, 2021 Oct 15, 2021
8-K Report | Data 8-K Sep 13, 2021 Sep 13, 2021
8-K Report | Data 8-K (GEOFF RESIGNATION) Sep 3, 2021 Sep 1, 2021
10-Q Report | Data 10-Q Aug 4, 2021 Jun 30, 2021
8-K Report | Data 8-K Aug 4, 2021 Aug 4, 2021
8-K Report | Data 8-K Jul 14, 2021 Jul 13, 2021
10-Q Report | Data 10-Q May 5, 2021 Mar 31, 2021
8-K Report 8-K May 5, 2021 May 5, 2021
10-K Report FORM 10-K Mar 24, 2021 Dec 31, 2020
8-K Report 8-K Mar 24, 2021 Mar 24, 2021
8-K Report FORM 8-K Mar 2, 2021 Feb 24, 2021
SC 13G Report Feb 10, 2021
8-K Report 8-K Feb 9, 2021 Feb 8, 2021